PK - Merz 200 mg/500 ml i.v. Solution for Infusion

Amantadine sulphate

Active Ingredients
Net Amount:
2 Infusion Bottles
Solution for Infusion
Active Substance :
Amantadine sulphate
* Directions for use and short product information have been uploaded in Turkish.

PK-MERZ® is a medicinal product administered by intravenous infusion.

In severe and life-threatening cases of Parkinson’s disease and during acute exacerbation of symptoms as emergency and intensive care treatment

In the case of temporary withdrawal of oral tablet therapy

In order to increase awareness and sensory perception (as a supplementary treatment agent in coma patients of varying ethiology, traumatic brain injury / surgery, delayed awakening after anesthesia and similar situations

Parkinson disease: If PK-MERZ® monotherapy treatment is to be started for the first time, treatment with 2 tablets per day should be started. The full activity begins to appear within 48 hours.Treatment should be started with 1 tablet per day (100 mg / day) in patients who have another medical illness or who take high dose of other antiparkinsonian drugs. After one or couple of weeks of treatment, the dose can be increased to 2 tablets (200 mg/day), which is taken at the standard level of 1 tablet twice daily.In patients who do not respond to a daily dose of 2 tablets (200 mg), the dose can be increased up to 4 tablets (400 mg) to be taken daily in a divided fashion. The dose should not exceed 6 tablets per day (600 mg).

Solution for infusion